These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33972257)

  • 1. Choice of β-Lactam Resistance Pathway Depends Critically on Initial Antibiotic Concentration.
    Ruelens P; de Visser JAGM
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0047121. PubMed ID: 33972257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
    Guthrie VB; Allen J; Camps M; Karchin R
    PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme Efficiency but Not Thermostability Drives Cefotaxime Resistance Evolution in TEM-1 β-Lactamase.
    Knies JL; Cai F; Weinreich DM
    Mol Biol Evol; 2017 May; 34(5):1040-1054. PubMed ID: 28087769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fitness of Beta-Lactamase Mutants Depends Nonlinearly on Resistance Level at Sublethal Antibiotic Concentrations.
    Farr AD; Pesce D; Das SG; Zwart MP; de Visser JAGM
    mBio; 2023 Jun; 14(3):e0009823. PubMed ID: 37129484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial mutations direct alternative pathways of protein evolution.
    Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
    PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene.
    Schenk MF; Szendro IG; Salverda ML; Krug J; de Visser JA
    Mol Biol Evol; 2013 Aug; 30(8):1779-87. PubMed ID: 23676768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolvability as a function of purifying selection in TEM-1 β-lactamase.
    Stiffler MA; Hekstra DR; Ranganathan R
    Cell; 2015 Feb; 160(5):882-892. PubMed ID: 25723163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Darwinian evolution can follow only very few mutational paths to fitter proteins.
    Weinreich DM; Delaney NF; Depristo MA; Hartl DL
    Science; 2006 Apr; 312(5770):111-4. PubMed ID: 16601193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
    Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
    Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended spectrum β-lactamase-producing Escherichia coli forms filaments as an initial response to cefotaxime treatment.
    Kjeldsen TS; Sommer MO; Olsen JE
    BMC Microbiol; 2015 Mar; 15():63. PubMed ID: 25888392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive Processes Change as Multiple Functions Evolve.
    Mira PM; Østman B; Guzman-Cole C; Sindi S; Barlow M
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis in
    Coolen JPM; den Drijver EPM; Verweij JJ; Schildkraut JA; Neveling K; Melchers WJG; Kolwijck E; Wertheim HFL; Kluytmans JAJW; Huynen MA
    Microb Genom; 2021 Apr; 7(4):. PubMed ID: 33843573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
    Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
    J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mistranslation can promote the exploration of alternative evolutionary trajectories in enzyme evolution.
    Zheng J; Bratulic S; Lischer HEL; Wagner A
    J Evol Biol; 2021 Aug; 34(8):1302-1315. PubMed ID: 34145657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid in vivo evolution of a beta-lactamase using phagemids.
    Long-McGie J; Liu AD; Schellenberger V
    Biotechnol Bioeng; 2000 Apr; 68(1):121-5. PubMed ID: 10699880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and
    Standley M; Blay V; Beleva Guthrie V; Kim J; Lyman A; Moya A; Karchin R; Camps M
    ACS Infect Dis; 2022 Dec; 8(12):2451-2463. PubMed ID: 36377311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum β-lactamase-producing Escherichia coli contributes to the survival of cefotaxime-susceptible E. coli under high concentrations of cefotaxime by acquisition of increased AmpC expression.
    Nakayama T; Kawahara R; Kumeda Y; Yamamoto Y
    FEMS Microbiol Lett; 2018 Mar; 365(5):. PubMed ID: 29361027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases.
    Rajer F; Allander L; Karlsson PA; Sandegren L
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0029022. PubMed ID: 35652643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.